Medical Radiology and Radiation Safety. 2023. Vol. 68. № 1

DOI: 10.33266/1024-6177-2023-68-1-72-77

A.A. Lemaeva, I.A. Gulidov

Radiation Therapy and Pregnancy (Literature Review)

A.F. Tsyb Medical Radiological Research Centre, Obninsk, Russia

Contact person: A.A. Lemaeva, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

ABSTRACT

The possibility of radiation therapy during pregnancy remains a subject of discussion, in most cases, specialists try to avoid the use of radiation therapy in a pregnant woman. Currently, there is insufficient data confirming the safety of intrauterine radiation even with the use of modern methods of radiation therapy. 

The purpose of this literature review is to summarize current clinical data on the appropriateness of the use and clinical results of the use of radiation therapy for the treatment of the most commonly diagnosed tumors in pregnant women.

Based on the literature data, it can be said that the possibility of using radiation therapy in the treatment of oncological diseases in pregnant women depends on the localization of the tumor, gestational age, the estimated total focal dose, the size of the irradiation field, the distance from the irradiation field to the fetus, the preferences of the patient.

Keywords: radiation therapy, pregnancy

For citation: Lemaeva AA, Gulidov IA. Radiation Therapy and Pregnancy (Literature Review). Medical Radiology and Radiation Safety. 2023;68(1):72–77. (In Russian). DOI: 10.33266/1024-6177-2023-68-1-72-77

 

References

1. Donegan W.L. Cancer and Pregnancy. CA Cancer J. Clin. 1983;33:194–214. 

2. Hay A.E., Klimm B., Chen B.E., et al. An Individual Patient-Data Comparison of Combined Modality Therapy and ABVD Alone for Patients with Limited-Stage Hodgkin Lymphoma. Ann. Oncol. 2013;24:3065–3069.

3. Mazzola R., GiajLevra N., Alongi F. Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma. J. Clin. Oncol. 2016;34;24:2940–2941.

4. Perez C.A., Grigsby P.W., Chao K.S., et al. Tumor Size, Irradiation Dose, and Longterm Outcome of Carcinoma of Uterine Cervix. Int. J. Radiat. Oncol. Biol. Phys. 1998;41;2:307–317.

5. Corradini S., Niyazi M., Niemoeller O.M., et al. Adjuvant Radiotherapy after Breast Conserving Surgery – a Comparative Effectiveness Research Study. Radiother. Oncol. 2015;114;1:28–34.

6. Mazzola R., Ricchetti F., Fiorentino A., et al. Weekly Cisplatin and Volumetric Modulated Arc Therapy with Simultaneous Integrated Boost for Radical Treatment of Advanced Cervical Cancer in Elderly Patients: Feasibility and Clinical Preliminary Results. Technology in Cancer Research & Treatment. 2017;16;3:310–315.

7. Nutting C.M., Morden J.P., Harrington K.J., et al. Parotid-Sparing Intensity Modulated Versus Conventional Radiotherapy in Head and Neck Cancer (PARSPORT): a Phase 3 Multicentrerandomised Controlled Trial. Lancet Oncol. 2011;12;2:127–136.

8. Mazzola R., Ferrera G., Alongi F., et al. Organ Sparing and Clinical Outcome with Step-and-Shoot IMRT for Head and Neck Cancer: a Mono-Institutional Experience. Radiol. Med. 2015;120;8:753–758.

9. GiajLevra N., Sicignano G., Fiorentino A., et al. Whole Brain Radiotherapy with Hippocampal Avoidance and Simultaneous Integrated Boost for Brain Metastases: a Dosimetric Volumetric-Modulated Arc Therapy Study. Radiol. Med. 2016;121;1:60–69.

10. Giaj-Levra N., Sciascia S., Fiorentino A., et al. Radiotherapy in Patients with Connective Tissue Diseases. Lancet Oncol. 2016;17;3:109–117.

11. Yoshimoto Y., Kato H., Schull W.J. Risk of Cancer among Children Exposed in Utero to A-Bomb Radiations. Lancet. 1988;2;8612:665–669.

12. Stovall M., Blackwell C.R., Cundiff J., et al. Fetal Dose from Radiotherapy with Photon Beams: Report of AAPM Radiation Therapy Committee Task Group No. 36. Medical Physics. 1995;22;1:63–82.

13. Nakagawa K., Aoki Y., Kusama T. Radiotherapy During Pregnancy: Effects on Fetuses and Neonates. Clinical Therapeutics. 1997;19:770–777.

14. Yonekura Y., Tsujii H., Hopewell, J.W., et al. International Commission on Radiological Protection. ICRP publication 127: Radiological Protection in Ion Beam Radiotherapy. Annals of the ICRP. 2014;43;4:5–113.

15. Otake M., Schull W.J. In Utero Exposure to A-Bomb Radiation and Mental Retardation: a Reassessment. The British Journal of Radiology. 1984;57: 409–414.

16. Miller R.W., Mulvihill J.J. Small Head Size after Atomic Irradiation. Teratology. 1976;14:355–358.

17. Mazzolaa R., Corradinib S., Eidemüeller M. Modern Radiotherapy in Cancer Treatment During Pregnancy. Critical Reviews in Oncology/Hematology. 2019;136:13-19.

18. Stewart A., Webb J., Giles D., et al. Malignant Disease in Childhood and Diagnostic Radiation in Utero. Lancet. 1956;1;271;6940:447.

19. Stewart A., Webb J., Hewitt D. A Survey of Childhood Malignancies. British Medical Journal. 1958;1;5086:1495–1508.

20. Bithell J.F., Draper G.J., Sorahan T., et al. Childhood Cancer Research in Oxford I: the Oxford Survey of Childhood Cancers. British Journal of Cancer. 2018;119;6:756–762.

21. Wakeford R., Little M.P. Risk Coefficients for Childhood Cancer after Intrauterine Irradiation: a Review. International Journal of Radiation Biology. 2003;79;5:293–309.

22. Chen Z., King W., Pearcey R., et al. The Relationship between Waiting Time for Radiotherapy and Clinical Outcomes: a Systematic Review of the Literature. Radiother Oncol. 2008;87;1:3–16.

23. Antypas C., Sandilos P., Kouvaris J., et al. Fetal Dose Evaluation During Breast Cancer Radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1998;1;40;4:995–999.

24. Ngu S.L., Duval P., Collins C. Foetal Radiation Dose in Radiotherapy for Breast Cancer. Aust. Radiol. 1992;36;4:321–322.

25. Van der Giessen P.H. Measurement of the Peripheral Dose for the Tangential Breast Treatment Technique with Co-60 Gamma Radiation and High Energy X-Rays. Radiother. Oncol. 1997;42;3:257–264.

26. Antolak J.A., Strom E.A. Fetal Dose Estimates for Electron-Beam Treatment to the Chest Wall of a Pregnant Patient. Med. Phys. 1998;25;12:2388–2391.

27. Van Calsteren K., Heyns L., De Smet, F., et al. Cancer During Pregnancy: an Analysis of 215 Patients Emphasizing the Obstetrical and the Neonatal Outcomes. J. Clin. Oncol. 2010;28;4:683–689.

28. Suwanbut P., Liamsuwan T., Nantajit D., Masa-Nga W., et al. Assessment of Fetal Dose and Health Effect to the Fetus from Breast Cancer Radiotherapy During Pregnancy. Life (Basel). 2022;12;1:84. 

29. Galimberti V., Ciocca M., Leonardi M.C., et al. Is Electron Beam Intraoperative Radiotherapy (ELIOT) Safe in Pregnant Women with Early Breast Cancer? In Vivo Dosimetry to Assess Fetal Dose. Ann. Surg. Oncol. 2009;16;1:100–105.

30. Leonardi M., Cecconi A., Luraschi R., et al. Electron Beam Intraoperative Radiotherapy (ELIOT) in Pregnant Women with Breast Cancer: from in Vivo Dosimetry to Clinical Practice. Breast Care (Basel). 2017;12;6:396–400.

31. Amant F., Deckers S., Van Calsteren K., et al. Breast Cancer in Pregnancy: Recommendations of an International Consensus Meeting. Eur. J. Cancer. 2010;46;18:3158–3168.

32. Amouzegar Hashemi F. Radiotherapy in Pregnancy-Associated Breast Cancer. Advances in Experimental Medicine and Biology. 2020;1252:125-127.

33. Gustaffson D.C., Kottmeier H.L. Carcinoma of the Cervix Associated with Pregnancy. A Study of the Radiumhemmet’s Series of Invasive Carcinoma During the Period 1932-1956. Acta Obstet. Gynecol. Scand. 1962;41:1–21.

34. Prem K.A., Makowski E.L., McKelvey J.L. Carcinoma of the Cervix Associated with Pregnancy. Am. J. Obstet. Gynecol. 1966;95;1:99–108.

35. Hunter M.I., Tewari K., Monk B.J. Cervical Neoplasia in Pregnancy. Part 2: Current Treatment of Invasive Disease. Am. J. Obstet. Gynecol. 2008;199:10–18.

36. Sood A.K., Sorosky J.I., Mayr N., et al. Radiotherapeutic Management of Cervical Carcinoma that Complicates Pregnancy. Cancer. 1997;80;6:1073–1078.

37. Woo S.Y., Fuller L.M., Cundiff J.H., et al. Radiotherapy During Pregnancy for Clinical Stages IA-IIA Hodgkin’s Disease. Int. J. Radiat. Oncol. Biol. Phys. 1992;23;2:407–412.

38. Lishner M., Zemlickis D., Degendorfer P., et al. Maternal and Foetal Outcome Following Hodgkin’s Disease in Pregnancy. Br. J. Cancer. 1992;65;1:114–117.

39. Evens A.M., Advani R., Press O.W., et al. Lymphoma Occurring During Pregnancy: Antenatal Therapy, Complications, and Maternal Survival in a Multicenter Analysis. J. Clin. Oncol. 2013;31;32:4132–4139. 

40. Haba Y., Twyman N., Thomas SJ., et al. Radiotherapy for Glioma During Pregnancy: Fetal Dose Estimates, Risk Assessment and Clinical Management. Clin. Oncol. (R Coll Radiol). 2004;16:210–214.

41. Mazonakis M., Damilakis J., Theoharopoulos N., et al. Brain Radiotherapy During Pregnancy: an Analysis of Conceptus Dose Using Anthropomorphic Phantoms. Br. J. Radiol. 1999;72:274–278.

42. Podgorsak M., Meiler R., Kowal H., et al. Technical Management of a Pregnant Patient Undergoing Radiation Therapy to the Head and Neck. Med. Dosim. 1999;24;2:121-128.

43. Nuyttens J.J., Prado K.L., Jenrette J.M., Williams T.E. Fetal Dose During Radiotherapy: Clinical Implementation and Review of the Literature. Cancer Radiother. 2002;6:352–357.

44. Sharma D.S., Jalali R., Tambe C.M., et al. Effect of Tertiary Multileaf Collimator (MLC) on Foetal Dose During Three-Dimensional Conformal Radiation Therapy (3DCRT) of a Brain Tumour During Pregnancy. Radiother Oncol. 2004;70:49–54.

45. Yu C., Jozsef G., Apuzzo ML, et al. Fetal Radiation Doses for Model C Gamma Knife Radiosurgery. Neurosurgery. 2003;52:687–693.

46. Magné N., Marcié S., Pignol J.P., et al. Radiotherapy for a Solitary Brain Metastasis During Pregnancy: a Method for Redu-
cing Fetal Dose. Br. J. Radiol. 2001;74:638–641.

 

 PDF (RUS) Full-text article (in Russian)

 

Conflict of interest. The authors declare no conflict of interest.

Financing. The study had no sponsorship.

Contribution. Article was prepared with equal participation of the authors.

Article received: 20.09.2022. Accepted for publication: 25.11.2022.